Transformando la práctica clínica del paciente con Cáncer de Pulmón ALK positivo

20 / 53

ALK-TKI Resistance Mechanisms
Crizotinib-resistant cases
Gainor JF, et al. Cancer Discov., 2016
Major resistance mechanism
Non-mutational
Not enough exposure of Criz
Bypass signaling
50-70%